Massachusetts Financial Services’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
Other funds holding STOK
LCM
Massachusetts Financial Services's STOK Position: Q3 2026 in Review
Massachusetts Financial Services sold out of Stoke Therapeutics (STOK) in Q3 2026, closing a stake of 10,829 shares — an estimated $354K sold.
Massachusetts Financial Services first reported a position in STOK in Q4 2025 and held it in 3 quarters. The position peaked at $737K in Q1 2026. 185 funds tracked by Wall St. Rank hold STOK as of Q3 2026.
- Massachusetts Financial Services reported no remaining Stoke Therapeutics position as of Q3 2026 after selling out during the quarter.
- Massachusetts Financial Services sold 10,829 Stoke Therapeutics shares in Q3 2026, an estimated $354K.
- Massachusetts Financial Services first reported a position in Stoke Therapeutics in Q4 2025 and held it in 3 quarters.
- Massachusetts Financial Services's Stoke Therapeutics position peaked at $737K in Q1 2026.
- 185 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q3 2026.
Based on Massachusetts Financial Services's 13F filing for Q3 2026, filed 12 Nov 2026.